MUC1 and interstitial lung disease: The data obtained from this study indicates that RF, ACPA, and anti-CarP antibodies are not good biomarkers for the diagnosis of ILD or CLD compared with the levels of KL-6 or SP-D (Tables 1 and 2, Supplementary Fig. S1).